Frontiers in Neurology (Jan 2024)

Clinical practice guidelines for the diagnosis and management of Duchenne muscular dystrophy: a scoping review

  • Marco Malaga,
  • Marco Malaga,
  • Aaron Rodriguez-Calienes,
  • Fabian A. Chavez-Ecos,
  • Fabian A. Chavez-Ecos,
  • Andrely Huerta-Rosario,
  • Andrely Huerta-Rosario,
  • Giancarlo Alvarado-Gamarra,
  • Giancarlo Alvarado-Gamarra,
  • Giancarlo Alvarado-Gamarra,
  • Miguel Cabanillas-Lazo,
  • Miguel Cabanillas-Lazo,
  • Paula Moran-Ballon,
  • Paula Moran-Ballon,
  • Victor Velásquez-Rimachi,
  • Victor Velásquez-Rimachi,
  • Peggy Martinez-Esteban,
  • Carlos Alva-Diaz,
  • Carlos Alva-Diaz,
  • Carlos Alva-Diaz

DOI
https://doi.org/10.3389/fneur.2023.1260610
Journal volume & issue
Vol. 14

Abstract

Read online

IntroductionOur objective was to identify recent CPGs for the diagnosis and management of DMD and summarize their characteristics and reliability.MethodsWe conducted a scoping review of CPGs using MEDLINE, the Turning Research Into Practice (TRIP) database, Google Scholar, guidelines created by organizations, and other repositories to identify CPGs published in the last 5 years. Our protocol was drafted using the Preferred Reporting Items for Systematic Reviews and Meta-analyses for scoping reviews. To assess the reliability of the CPGs, we used all the domains included in the Appraisal of Guidelines Research and Evaluation II.ResultsWe selected three CPGs published or updated between 2015 and 2020. All the guidelines showed good or adequate methodological rigor but presented pitfalls in stakeholder involvement and applicability domains. Recommendations were coherent across CPGs on steroid treatment, except for minor differences in dosing regimens. However, the recommendations were different for new drugs.DiscussionThere is a need for current and reliable CPGs that develop broad topics on the management of DMD and consider the challenges of developing recommendations for RDs.

Keywords